Year: 2011 (Page 1 of 2)

My story on private interests in global health, now at Foreign Affairs.com

Xavier Donat/flickr

Xavier Donat/flickr

In this piece, I look at how major private industry–oil and gas companies, the fast-food industry, and Big Pharma–are transforming the global health agenda. In sum: it’s not good. The story is the product of about 6 months of research, supported by the Investigative Fund of the Nation Institute. Check it out here.

“How Private Companies Are Transforming the Global Health Agenda: A New Era for the World Health Organization,” by Sonia Shah, Foreign Affairs.com, November 9, 2011

Frederick, MD

October 23, 2012. 12:30 pm. “The Body Hunters: Big Pharma’s Quest for Miracle Drugs and its Impact on the Health and Human Rights of the Poor.” Q&A to follow. Open to the public. Frederick Community College, Frederick, MD

My Wall Street Journal review of "Lifeblood" by Alex Perry

Alex Perry, of TIME magazine, shadowed millionaire investor-turned-malaria activist Ray Chambers, the UN Special Envoy for malaria, as he attempted to blanket the continent of Africa with treated bednets, and then wrote this short book about it, which I reviewed for The Wall Street Journal. It was a difficult review to write, because while I admire Perry as a reporter, I had many objections to the way he talks about malaria. I could only fit in a few in the review. Here’s the link.

Are treated bednets failing?

are treated bednets failing?

are treated bednets failing?

The LLIN—“long lasting insecticide treated net”—is actually not very long lasting, after all. Years ago when I first started learning about them, I was told by experts that they were meant to last 3-5 years. That’s longer than older model nets, but for a disease as pernicious as malaria it is really not particularly long at all. Many of the most avid net distributors and fundraisers have tended to sideline this rather salient fact. Well, now good evidence has emerged that these nets indeed last for three years—and three years only—throwing into question the very idea that “nets save lives.” Perhaps the mantra should be “nets delay malaria for a few years.”

Between January 2007 and July 2008, the incidence of malaria among the people of Dielmo, Senegal ran to around 5.45 per 100 person-months. This village has been studied by the Pasteur Institute since 1990, when they started systematically testing the blood of people with fever for malaria parasites. People there get about 258 bites from infected mosquitoes every year. In 2008, LLINs were distributed, and incidence dropped dramatically, to just .41 per 100 person-months.

Two and a half years passed.

And then the nets stopped working.

Malaria spiked back up to 4.57 per 100 person-months, nearly the same level as it was before the nets were distributed. And all those little kids who’d been sleeping under them—now a bit older—started getting sick with malaria.

Generally, malaria cases in endemic areas are concentrated in pregnant women and children under five years old. Older children and adults, having acquired some immunity to the malaria parasite, generally don’t get as sick, and few die of malaria. Except in Dielmo, where researchers were actively surveilling the population, testing people with fevers for malaria. There, most of the rebound in cases in 2010 occurred in adults and children who were 10 years old or older, suggesting that these individuals had been stripped of their acquired immunity during the years when the nets protected them from exposure to malaria.

Indeed, when the researchers analyzed local Anopheles gambiae mosquitoes, they found the telltale kdr mutation, which confers resistance to pyrethroid insecticides, of the kind used in nets. The frequency of that gene in the local mosquitoes increased from just 8 percent in 2007 to 48 percent in 2010. (The nets were samples and checked for insecticidal activity and holes and the like and were found to be intact.)

So, was anyone’s life saved? What was the (ahem) net effect of all those nets?

For more, see: Jean-Francois Trape et al., “Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study,” The Lancet Infectious Diseases, In Press, Corrected Proof, Available online 17 August 2011, ISSN 1473-3099, DOI: 10.1016/S1473-3099(11)70194-3.

Is history repeating itself?

Anyone familiar with the history of malaria control will find the below article, from NatureNews, unsettlingly familiar. Western donors  flood the malarious world with insecticide-treated bednets, and foresee malaria’s impending demise. Experts warn that the mosquitoes will learn to rout the chemical blitz; supporting evidence piles up, and is ignored; the years go by. Then, just as financing for the chemical blitz becomes shaky, we hear official recognition of the increasing weakness of anti-malarial insecticides. Now, more money will be needed to develop alternative insecticides, or use combinations of insecticides, but of course there is less money to go around, and many millions of nets treated with the old, increasingly ineffective insecticides hang in huts across Africa. Who will replace them? And with what? And how?

See “Mosquitoes score in chemical war: Growing resistance is threatening global malaria-control efforts,” NatureNews, July 5, 2011.

And check out a very similar story, from 1952, which presaged the collapse of the DDT blitz against malaria, and its subsequent resurgence in the 1980s and 1990s: “Mosquitoes developing an armor against DDT after 9-year-war,” New York Times, March 14, 1952. (For more, see my chapter on “The spraygun war” in The Fever.)

The Guardian's take on our panel at the World Conference of Science Journalists

In the end, I had to Skype in to this year’s World Conference of Science Journalists conference in Doha, Qatar, and deliver my presentation on the issue of drug trials in developing countries via YouTube video. (You can check it out here.) Here’s what the Guardian newspaper had to say about it. “Ethics left behind as drug trials soar in developing countries,” The Guardian, July 4, 2011.

« Older posts

© 2024 Sonia Shah

Site by NormanUp ↑